Joris Komen

8PUBLICATIONS
22CO-AUTHORS
Respiratory diseasesCardiology (incl. cardiovascular diseases)Haematological tumoursPacific Peoples cultural determinants of healthEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 18, 2026
Edoxaban for atrial fibrillation in patients with atherosclerotic disease in daily clinical practice.

|Mar 10, 2022
Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study.

Joris J Komen, Anton Pottegård, Aukje K Mantel-Teeuwisse

|Aug 03, 2021
Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds.

Joris Komen, Anton Pottegård, Paul Hjemdahl

|Jun 07, 2021
Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries.

Joris J Komen, Anton Pottegård, Aukje K Mantel-Teeuwisse

|Mar 18, 2021
Greedy caliper propensity score matching can yield variable estimates of the treatment-outcome association-A simulation study.

Joris J Komen, Svetlana V Belitser, Richard Wyss

|Dec 14, 2020
Comparative effectiveness and safety of direct oral anticoagulants versus warfarin in UK patients with atrial fibrillation and type 2 diabetes: A retrospective cohort study.

Fatma Rustem Gulluoglu, Patrick C Souverein, Hendrika A van den Ham

Pageof 2

Frequent Collaborators

2 joint publications

Tomas Forslund

2 joint publications

Paul Hjemdahl

2 joint publications

Jesper Hallas

1 joint publications

Romin Pajouheshnia